Abstract
Buspirone is renowned for its highly inconsistent effects in animal models of anxiety. In the present study, the effects of acute (0.63–5.0 mg/kg) and chronic (1.25–5.0 mg/kg, daily, 15 days) buspirone treatment on the behaviour of mice in the elevated plus-maze test were assessed using a recently developed ethological scoring method. On acute administration, a selective reduction in risk assessment behaviours was observed at 1.25 mg/kg; these mild anxiolytic-like effects were maintained at higher doses (2.5–5.0 mg/kg) which also reduced measures of general activity. Similar, though more potent, effects were observed with chronic administration; the lowest dose tested (1.25 mg/kg) reduced open arm entries and total stretch attend postures while higher doses profoundly reduced all major indices of anxiety (traditional and novel) and, concomitantly, suppressed total entries and rearing. Acute administration of haloperidol (0.0125–0.1 mg/kg) appeared to mimic the behavioural suppressant effects of buspirone without selectively affecting anxiety-related measures at any dose. It is suggested that the anti-anxiety and behavioural suppressant profile of buspirone may reflect combined action at 5-HT1A and D2 receptors, respectively. Results are discussed in relation to the utility of risk assessment as a sensitive index of anxiety in models based upon unconditioned behaviour.
Similar content being viewed by others
References
Anderson ML, Taukulis HK (1993) Behavioral profiles of buspirone, diazepam, and yohimbine in a predator-odor screening test for anxiolytics. Drug Dev Res (in press).
Barrett JE (1992) Studies on the effects of 5-HT1A drugs in the pigeon. Drug Dev Res 26:299–317
Blanchard DC, Rodgers RJ, Hendrie CA, Hori K (1988) “Taming” of wild rats (Rattus rattus) by 5-HT1A agonists buspirone and gepirone. Pharmacol Biochem Behav 31:269–278
Blanchard DC, Shepherd JK, Rodgers RJ, Blanchard RJ (1992) Evidence for differential effects of 8-OH-DPAT on male and female rats in the anxiety/defense test battery. Psychopharmacology 106:531–560
Blanchard DC, Weatherspoon A, Shepherd JK, Rodgers RJ, Blanchard RJ (1991) “Paradoxical” effects of morphine on antipredator defense reactions in wild and laboratory (R. norvegicus) rats. Pharmacol Biochem Behav 40:819–828
Blanchard RJ, Blanchard DC, Rodgers RJ, Weiss SM (1990a) The characterization and modelling of antipredator defensive behavior. Neurosci Biobehav Rev 14:463–472
Blanchard RJ, Blanchard DC, Weiss SM (1990b) Effects of ethanol and diazepam on reactivity to predatory odors. Pharmacol Biochem Behav 35:775–780
Blanchard RJ, Shepherd JK, Rodgers RJ, Magee L, Blanchard DC (1993a) Attenuation of antipredator defensive behaviour in rats following chronic treatment with imipramine. Psychopharmacology 110:245–253
Blanchard RJ, Rodgers RJ, Blanchard DC (1993b) Ethological approaches to the preclinical psychopharmacology of anxiety. In: Palomo T (ed) Strategies for studying CNS active compounds, (in press)
Brett RR, Pratt JA (1990) Chronic handling modifies the anxiolytic effect of diazepam in the elevated plus-maze. Eur J Pharmacol 178:135–138
Cole JC, Rodgers RJ (1993) An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16–6028) in the murine elevated plus-maze. Behav Pharmacol (in press)
Costall B, Hendrie CA, Kelly ME, Naylor RJ (1987) Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology 26:195–200
Critchley MAE, Handley SL (1987) Effects in the X-maze model of agents acting at 5-HT1 and 5-HT2 receptors. Psychopharmacology 93:502–506
Culter MG (1991) An ethological study of the effects of buspirone and the 5-HT3 receptor antagonist, BRL 43694 (granisetron) on behaviour during social interactions in female and male mice. Neuropharmacology 30:299–306
Dunn RW, Corbett R, Fielding S (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus-maze. Eur J Pharmacol 169:1–10
Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms in the behavioral effects of buspirone. Pharmacol Biochem Behav 24:701–707
Falter U, Gower AJ, Gobert J (1992) Resistance of baseline activity in the elevated plus-maze to exogenous influences. Behav Pharmacol 3:123–128
File SE, Andrews N (1991) Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal. Psychopharmacology 105:578–582
Gao B, Cutler MG (1992) Effects of subchronic treatment with chlordiazepoxide, busprione and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice. Neuropharmacology 31:207–214
Goa K, Ward A (1986) Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114–129
Grant EC, Mackintosh JH (1963) A comparison of the social postures of some common laboratory rodents. Behaviour 21:246–259
Hamon M, Fattaccini CM, Adrien J, Gallissot M-C, Martin P, Gozlan H (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther 246:745–752
Howard JL, Pollard GT (1990) Effects of buspirone in the Geller-Seifter conflict test with incremental shock. Drug Dev Res 19:37–49
Hoyer D (1991) The 5-HT receptor family: ligands, distribution and receptor-effector coupling. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, Chichester, pp 31–57
Hoyer D (1992) Agonists and antagonists at 5-HT receptor subtypes. In: Bradley PB, Handley SL, Cooper SJ, Key BJ, Barnes NM, Coote JH (eds) Serotonin, CNS receptors and brain function. Pergamon, Oxford, pp 29–47
Kaesermann H-P (1986) Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action. Psychopharmacology 89:31–37
Kostowski W, Dyr W, Krzascik P, Jarbe T, Archer T (1992) 5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety. Pharmacol Toxicol 71:24–30
Klint T (1991) Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats. Behav Pharmacol 2:481–489
Lal H, Prather PL, Rezazadeh SM (1991) Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 8:467–471
Lee C, Rodgers RJ (1991) Effects of buspirone in antinociceptive and behavioural responses to the elevated plus-maze. Behav Pharmacol 2:491–496
Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185
Luscombe GP, Mazurkiewicz SE, Heal DJ (1992) The 5-HT1A lig-and BP 554 mimics the anxiolytic activity of buspirone, gepirone and ipsapirone in the elevated plus-maze in rats. Br J Pharmacol 106:130P
McMillen BA, Matthews RT, Sanghera MK, Shepard PD, German DC (1983) Dopamine receptor antagonism by the novel anti-anxiety drug, buspirone. J Neurosci 3:733–738
Montgomery KC (1958) The relation between fear induced by novelty stimulation and exploratory behaviour. J Comp Physiol Psychol 48:254–260
Moser P (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99:48–53
Moser P, Tricklebank MD, Middlemiss DN, Mir AK, Hibert MF, Fozard (1990) Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone. Br J Pharmacol 99:343–349
Motta V, Maisonette S, Morato S, Castrechini P, Brandao ML (1992) Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze. Psychopharmacology 107:135–139
Panickar KS, McNaughton N (1991) Dose-response analysis of the effects of buspirone on rearing in rats. J Psychopharmacology 5:72–76
Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem behav 24:525–529
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167
Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-Hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39:917–928
Pich EM, Samanin R (1986) Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine. Psychopharmacology 89:125–130
Rodgers RJ (1991) A step in the right direction: comment on “5-HT and mechanisms of defence”. J Psychopharmacol 5:316–319
Rodgers RJ, Cole JC (1993) Anxiety enhancement in the murine elevated plus-maze by immediate prior exposure to social stressors. Physiol Behav 53:383–388
Rodgers RJ, Cole JC, Cobain MR, Daly P, Doran PJ, Eells JR, Wallis P (1992) Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP. Behav Pharmacol 3:621–634
Rodgers RJ, Shepherd JK (1989) Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone. Psychopharmacology 99:364–380.
Schweizer E, Rickels K (1991) Serotonergic anxiolytics: a review of their clinical efficacy. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, Chichester, pp 365–376
Soderpalm B, Hjorth S, Engel JA (1989) Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav 32:259–265
Taylor DP, Moon SL (1991) Buspirone and related compounds as alternative anxiolytics. Neuropeptides 19 [Suppl 1]: 15–19
Taylor DP, Eison MS, Riblet LA, VanderMaelen CP (1985) Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23:687–694
Tompkins EC, Clemento AJ, Taylor DP, Perhach JL (1980) Inhibition of aggressive behavior in rhesus monkeys by buspirone. Res Commun Psychol Psychiatr Behav 5:337–352
Treit D (1991) Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models. In: Rodgers RJ, Cooper SJ (eds) 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Wiley, Chichester, pp 107–131
Wada T, Fukuda N (1991) Effects of DN-2337, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze. Psychopharmacology 104:444–450
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cole, J.C., Rodgers, R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology 114, 288–296 (1994). https://doi.org/10.1007/BF02244851
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244851